Origen Therapeutics, Inc. and Embrex, Inc. today announced a research collaboration aimed at combining Origen's avian embryonic stem (ES) cell technology with Embrex's in ovo technology. The goal of the collaboration is to develop methods that enhance poultry production and chick quality early in embryonic development.